Previous close | 263.00 |
Open | 263.00 |
Bid | 243.40 |
Ask | 249.45 |
Strike | 490.00 |
Expiry date | 2024-06-21 |
Day's range | 263.00 - 263.00 |
Contract range | N/A |
Volume | |
Open interest | 55 |
ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]